Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 3Weight Loss 1SCLC, Limited Stage 1Pediatric Obesity 1Pain, Postoperative 1Obesity 1Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Laryngeal Neoplasms 1Gynecologic Oncology Patient 1Emotional Regulation 1Cognitive Dysfunction 1Anxiety Disorders 1

Interventions

Dexamethasone 238Lenalidomide 145daratumumab 123Bortezomib 101pomalidomide 86Calcium Dobesilate 76carfilzomib 74Cyclophosphamide 70Specimen Handling 42isatuximab 40Biopsy 40fludarabine 36belantamab mafodotin 36Magnetic Resonance Spectroscopy 35talquetamab 29dexamethasone acetate 27dexamethasone 21-phosphate 27Melphalan 27auricularum 26iberdomide 25ixazomib 22fludarabine phosphate 22selinexor 21elotuzumab 21Whole-Body Irradiation 14X-Rays 13tocilizumab 12venetoclax 11Mycophenolic Acid 10trametinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Population Groups × 1 year × Clear all
NCT07236021 2025-11-21

e-Motion : Promoting Emotion Regulation in Chronic Cancer

Université Libre de Bruxelles

Phase NA Recruiting
30 enrolled
Plasma cell

Emotional Regulation, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡